BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34196517)

  • 1. A Deep Dive: SIWV Tetra-Peptide Enhancing the Penetration of Nanotherapeutics into the Glioblastoma.
    Kang RH; Park J; Kim J; Chowdhury T; Oh JH; Kim J; Shin J; Kim M; Park CK; Lee S; Lee JY; Kim D
    ACS Biomater Sci Eng; 2022 Oct; 8(10):4163-4174. PubMed ID: 34196517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A brain tumor-homing tetra-peptide delivers a nano-therapeutic for more effective treatment of a mouse model of glioblastoma.
    Kang RH; Jang JE; Huh E; Kang SJ; Ahn DR; Kang JS; Sailor MJ; Yeo SG; Oh MS; Kim D; Kim HY
    Nanoscale Horiz; 2020 Jul; 5(8):1213-1225. PubMed ID: 32510090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
    Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
    ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multifunctional Porous Silicon Nanocarrier for Glioblastoma Treatment.
    Luo M; Li Y; Peng B; White J; Mäkilä E; Tong WY; Jonathan Choi CH; Day B; Voelcker NH
    Mol Pharm; 2023 Jan; 20(1):545-560. PubMed ID: 36484477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
    Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
    Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery.
    Zhao J; Zhang B; Shen S; Chen J; Zhang Q; Jiang X; Pang Z
    J Colloid Interface Sci; 2015 Jul; 450():396-403. PubMed ID: 25863222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Glioblastoma Visualization: Triple Receptor-Targeting Fluorescent Complex of Dye, SIWV Tetra-Peptide, and Serum Albumin Protein.
    An JM; Moon H; Verwilst P; Shin J; Kim BM; Park CK; Kim JS; Yeo SG; Kim HY; Kim D
    ACS Sens; 2021 Jun; 6(6):2270-2280. PubMed ID: 34100604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.
    Tong WY; Alnakhli M; Bhardwaj R; Apostolou S; Sinha S; Fraser C; Kuchel T; Kuss B; Voelcker NH
    J Nanobiotechnology; 2018 Apr; 16(1):38. PubMed ID: 29653579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.
    Chen X; Tai L; Gao J; Qian J; Zhang M; Li B; Xie C; Lu L; Lu W; Lu W
    J Control Release; 2015 Nov; 218():29-35. PubMed ID: 26428461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
    Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
    Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy.
    Song S; Mao G; Du J; Zhu X
    Drug Deliv; 2016 May; 23(4):1404-8. PubMed ID: 26203687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
    Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
    AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
    Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q
    Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures.
    Gonçalves DPN; Rodriguez RD; Kurth T; Bray LJ; Binner M; Jungnickel C; Gür FN; Poser SW; Schmidt TL; Zahn DRT; Androutsellis-Theotokis A; Schlierf M; Werner C
    Acta Biomater; 2017 Aug; 58():12-25. PubMed ID: 28576716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies.
    Fadera S; Chen PY; Liu HL; Lee IC
    ACS Appl Mater Interfaces; 2021 Jul; 13(28):32845-32855. PubMed ID: 34235925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
    Xin H; Sha X; Jiang X; Zhang W; Chen L; Fang X
    Biomaterials; 2012 Nov; 33(32):8167-76. PubMed ID: 22889488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
    Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
    Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinacrine Mediated Sensitization of Glioblastoma (GBM) Cells to TRAIL through MMP-Sensitive PEG Hydrogel Carriers.
    Erkoc P; Cingöz A; Onder TB; Kizilel S
    Macromol Biosci; 2017 Feb; 17(2):. PubMed ID: 27762493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.
    Sukumar UK; Bose RJC; Malhotra M; Babikir HA; Afjei R; Robinson E; Zeng Y; Chang E; Habte F; Sinclair R; Gambhir SS; Massoud TF; Paulmurugan R
    Biomaterials; 2019 Oct; 218():119342. PubMed ID: 31326657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration.
    Gao H; Xiong Y; Zhang S; Yang Z; Cao S; Jiang X
    Mol Pharm; 2014 Mar; 11(3):1042-52. PubMed ID: 24521297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.